Featured in the IBA Healthcare and Life Sciences Law Committee eBulletin
We recently contributed three articles to the IBA Healthcare and Life Sciences Law Committee eBulletin, exploring key legal and regulatory developments for life sciences businesses.
Cybersecurity and the life sciences sector: the NIS2 Directive
Julie Austin and Jamie Gallagher explore what NIS2 means for life sciences organisations, including incident reporting and supply chain obligations.
Digital therapeutics and AI-driven health apps: regulatory and intellectual property considerations
Michaela Herron, Jamie Gallagher and Hazel McDwyer provide an overview of the fast-moving digital health landscape.
Environmental sustainability and ESG compliance in the life sciences industry
Jay Sattin and Jenny Kelehan discuss sustainability requirements for the life sciences sector, including those related to batteries, chemicals and micropollutants.
For more information and expert advice, please reach out to a member of our Life Sciences team.
The content of these articles are provided for information purposes only and do not constitute legal or other advice.
Share this: